PEPFAR

These global health budget summaries highlight key information about global health funding levels throughout the federal budget and appropriations process.

This fact sheet summarizes the major statutory requirements and policies pertaining to U.S. global family planning/reproductive health (FP/RH) efforts over time and identifies those currently in effect.

As Congress considers reauthorization of the President’s Emergency Plan for AIDS Relief (PEPFAR) for a fourth time, KFF explores the debate over abortion policy that has stalled the legislation and the potential implications if Congress does not reauthorize the program. PEPFAR spans more than 50 countries and has been reported…

This updated fact sheet examines the U.S. role in the Global Fund, an independent, multilateral financing entity that raises significant new resources to combat HIV/AIDS, tuberculosis (TB), and malaria in low- and middle- income countries.

This policy watch provides an overview of the current debate and key questions related to abortion surrounding the fourth reauthorization of PEPFAR.

This dashboard monitors progress being made to address the HIV/AIDS epidemic in countries where PEPFAR operates. It includes data for 54 countries and tracks progress against 6 different indicators.

This updated fact sheet provides the latest data on the global HIV/AIDS epidemic, including impact on affected and vulnerable populations, treatment and prevention efforts, and an overview of the U.S. and global responses to the epidemic.

This fact sheet explores the history, funding, and future outlook of the President’s Emergency Plan for AIDS Relief (PEPFAR), the U.S. government’s major global initiative to combat HIV/AIDS.

This data note arrays and groups PEPFAR countries by their level of “sustainability readiness” in order to help inform discussions about PEPFAR’s work on sustainability,

This report tracks funding levels of the donor governments that collectively provide the bulk of international assistance for AIDS through bilateral programs and contributions to multilateral organizations. Overall, the analysis shows that while donor government funding for HIV increased between 2021 and 2022, this was primarily due to the timing of payments from the U.S. government and not actual increases in commitments.